Sign in

CIK 0001010086

  • Accelerated filer

SIGA TECHNOLOGIES INC

Sign in to watch
Ticker
SIGA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133864870
Phone
+1 212-672-9100
Business address
31 EAST 62ND STREET, NEW YORK, NY, 10065
Former names
SIGA PHARMACEUTICALS INC
  1. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  2. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  3. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  4. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  5. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  6. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  7. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  8. 4 Exercise or conversion Director acquired 15,000 shares (option exercise)
  9. 4 Open-market buy Director bought 20,000 shares at $4.37 ($87,400)
  10. 4 Open-market buy Director bought 2,500 shares at $4.39 ($10,975)
  11. 4 Open-market buy Chief Executive Officer bought 10,000 shares at $4.42 ($44,200)
  12. 4 Open-market buy Executive VP & CFO bought 5,000 shares at $4.39 ($21,950)
  13. 4 Shares withheld for taxes Chief Executive Officer gave up 144,028 shares (to pay taxes)
  14. 4 Shares withheld for taxes Director gave up 54,501 shares (to pay taxes)
  15. 4 Open-market buy Director bought 10,000 shares at $4.95 ($49,500)
  16. 4 Open-market buy Director bought 10,000 shares at $5.08 ($50,800)
  17. 4 Shares withheld for taxes Executive VP & CFO gave up 12,788 shares (to pay taxes)
  18. 4 Shares withheld for taxes General Counsel and CAO gave up 12,788 shares (to pay taxes)
  19. 4 Open-market buy Director bought 12,500 shares at $5.74 ($71,750)
  20. 4/A Open-market buy Director bought 8,284 shares at $3.59 ($29,740)

Page 6 of 25 · 495 filings